COMPANY

ViCardia Therapeutics

HQ: San Francisco, CA source · vicardia.com ↗

Keywords: rare disease rare diseases

Location: San Francisco, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $700K (Form D filed May 21, 2026). SEC Form D 0002135564-26-000001 (May 21, 2026)
Evidence (1 event)
- May 21, 2026 · SEC Form D 0002135564-26-000001
  Name of Issuer: ViCardia Therapeutics, Inc.; CIK: 2135564; Address: San Francisco, CA; Submission type: D; Filing date: 2026-05-21; Industry Group: Biotechnology; Date of First Sale: 2026-05-19; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 700000; Total Amount Sold: 700000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals